← FDA Drug Approvals (Drugs@FDA)

POTASSIUM PHOSPHATES

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL · Approved 2023-10-10

Drug application

FDA Application #

ANDA216344

Application type

Abbreviated New Drug Application (Generic)

Brand name

POTASSIUM PHOSPHATES

Generic name

POTASSIUM PHOSPHATE, MONOBASIC POTASSIUM PHOSPHATE, DIBASIC INJECTION,

Active ingredients

POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

AMNEAL

Manufacturer

Amneal Pharmaceuticals Private Limited

First approval

2023-10-10

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown